Shaoyao Gancao Decoction as an adjunct to conventional Western medicine improves pain relief and sleep quality in patients with postherpetic neuralgia
This meta-analysis of 15 RCTs (1,188 patients) found that adding Shaoyao Gancao Decoction (SGD) to conventional Western medicine significantly improved overall response rate (OR=5.42, 95% CI: 3.40-8.64), reduced VAS pain scores (MD=-1.33, 95% CI: -1.68 to -0.99), improved PSQI sleep scores (MD=-2.23, 95% CI: -2.85 to -1.62), and reduced adverse events (OR=0.34, 95% CI: 0.21-0.56) compared to Western medicine alone.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Shaoyao Gancao Decoction as an adjunct to conventional Western medicine improves pain relief and sleep quality in patients with postherpetic neuralgia The current body of evidence comprises 1 study and 1 meta-analysis. EvidenceHub rates the overall confidence at 49/100 (low).
The Claim
Shaoyao Gancao Decoction as an adjunct to conventional Western medicine improves pain relief and sleep quality in patients with postherpetic neuralgia
This conclusion is most relevant to: Patients with postherpetic neuralgia (PHN), a subtype of neuropathic pain.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Shaoyao Gancao decoction for neuropathic pain: a systematic review and meta-analysis of postherpetic neuralgia. (American journal of translational research, 2026) —
How It Works
The proposed biological pathway:
- ▸SGD contains active compounds (e.g., paeoniflorin, glycyrrhizin) with anti-inflammatory and analgesic properties
- ▸These compounds may modulate neuropathic pain pathways, reducing central sensitization
- ▸Improved pain control leads to better sleep quality and reduced pain-related sleep disturbance
- ▸Result: Enhanced overall treatment response and reduced adverse events
Who Might Benefit
Evidence fit by population:
- ▸Patients with postherpetic neuralgia (PHN), a subtype of neuropathic pain
Recommended Dose
N/A (not specified in abstract)
Limitations & Caveats
Important context when interpreting this evidence:
- ▸High heterogeneity observed in VAS analysis (I2=97%), though subgroup and sensitivity analyses suggested robustness
- ▸Only PHN subtype was analyzed; generalizability to other neuropathic pain types is uncertain
- ▸Potential publication bias not explicitly addressed in abstract
- ▸Duration of treatment varied (14 and 28 days), which may affect outcomes
Frequently Asked Questions
What is Shaoyao Gancao Decoction?▼
Shaoyao Gancao Decoction is a traditional Chinese herbal formula composed of Paeonia lactiflora (Shaoyao) and Glycyrrhiza uralensis (Gancao), used for pain relief.
How does SGD improve sleep in PHN patients?▼
By reducing neuropathic pain intensity (VAS score), SGD likely alleviates pain-related sleep disturbances, leading to improved PSQI scores.
Is SGD safe to use with conventional Western medicine?▼
The meta-analysis found a lower incidence of adverse events in the SGD group (OR=0.34), suggesting good safety as an adjunctive therapy.
Can SGD be used for other types of neuropathic pain?▼
The authors suggest potential value for other NP types (e.g., diabetic peripheral neuropathy), but further research is needed.
References
- 1.Zhao J, Wang F, Wang F, Ma L. “Shaoyao Gancao decoction for neuropathic pain: a systematic review and meta-analysis of postherpetic neuralgia..” American journal of translational research, 2026. PMID: 42631154 DOI: 10.62347/AEVA1650